483
Edlaw Pharmaceutical, Inc.Edlaw Pharmaceutical, Inc. – FDA 483, Nov 27, 2019
Record Details
An FDA inspection of Edix Pharmaceutical, Inc., a medical device repackager and relabeler in Farmingdale, NY, revealed significant deficiencies in their quality system. The firm failed to maintain written Medical Device Reporting (MDR) procedures and did not perform quality internal audits at defined intervals. These issues indicate a lack of adequate controls for adverse event reporting and overall quality system oversight.
View Company Profile
ID · 920d7f2b-2b35-44c5-98d9-dd93dd4821ba
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.